Search - tctmd.com

Displaying 321 - 340 of 611

Sort: Relevancy | Date

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

News Conference News TCT 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

September 24, 2018

Polymer-Free BioFreedom Stent as Safe as Orsiro, but Not as Effective

News Conference News TCT 2018

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

Michael O'Riordan

September 22, 2018

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

News Opinion Editor's Corner TCT 2018

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

September 22, 2018

High-STEACS: Sensitive Troponin Tests Rule Out MI, but Have No Impact on Hard Events

News Conference News ESC 2018

High-STEACS: Sensitive Troponin Tests Rule Out MI, but Have No Impact on Hard Events

August 29, 2018

VERDICT: Very Early Invasive Angiography No Help Overall for NSTE ACS

News Conference News ESC 2018

VERDICT: Very Early Invasive Angiography No Help Overall for NSTE ACS

August 29, 2018

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

News Conference News ESC 2018

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

Michael O'Riordan

August 28, 2018

Ten-Year Follow-up Proves Disappointing for Bilateral Arterial Grafts in ART

News Conference News ESC 2018

Ten-Year Follow-up Proves Disappointing for Bilateral Arterial Grafts in ART

August 26, 2018

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

News Conference News ESC 2018

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

Michael O'Riordan

August 25, 2018

CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients

News Conference News ESC 2018

CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients

August 25, 2018

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

News Daily News

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

Michael O'Riordan

July 06, 2018

New Review Probes Possibility of CVD Prevention Without Aspirin

News Daily News

New Review Probes Possibility of CVD Prevention Without Aspirin

Michael O'Riordan

July 04, 2018

NOACs Carry Lower MI Risk vs Warfarin in Real-world Study

News Daily News

NOACs Carry Lower MI Risk vs Warfarin in Real-world Study

June 25, 2018

News Industry News

Essential Medical Announces Positive Results from The Safe Manta Clinical Trial, The First Pivotal Trial for a Dedicated Large Bore Closure Device

June 25, 2018

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

News Features

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

June 08, 2018

DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis

News Conference News EuroPCR 2018

DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis

May 30, 2018

Chinese Firehawk Stent Performs Well Against Xience in All-Comers Study

News Conference News EuroPCR 2018

Chinese Firehawk Stent Performs Well Against Xience in All-Comers Study

Michael O'Riordan

May 29, 2018

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

News Daily News

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Michael O'Riordan

May 21, 2018

Spin to Win: Results From Late Breaking Meeting Trials Often Overstated

News Daily News

Spin to Win: Results From Late-Breaking Meeting Trials Often Overstated

May 15, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.